In this study we looked at clinical outcomes of patients who underwent cardioversion in the non-interventional Global Anticoagulant Registry in the FIELD-AF (GARFIELD-AF). 44 201 patients were included in an analysis comparing patients who received a baseline cardioversion with those… Read More ›
Thank you all for tuning in to this year’s afib.no meeting! We were thrilled to see so many of you there and impressed by the quality of the presentations. Day 1 started with the team behind the NEXAF study, who… Read More ›
Network members Eivind Sørensen (The Birkebeiner II Study), Turid Apelland, André La Gerche and Marius Myrstad (The NEXAF Detraining Study) attended the Pro@Heart Symposium in Leuven, Belgium September 24-26 2021. “Protecting the athlete by improving our understanding of athlete’s physiology”… Read More ›
High persistence and adherence among NOAC users Adequate persistence and adherence with non-vitamin K antagonists (NOACs) is essential for optimal stroke prevention in atrial fibrillation (AF), but large-scale studies comparing the different NOACs has been lacking. In a study recently… Read More ›
More than 50 researchers from Norway, Sweden, Denmark, Germany, The Netherlands, UK and Canada connected for a workshop on Atrial Remodeling in AF on Thursday April 15. The meeting started with one of the keynote speakers, dr. Pyotr Platonov who… Read More ›
Our colleague Rikke Buhl in Copenhagen, Denmark, has a new, exciting project on paroxysmal AF in horses. She would appreciate our help in collecting used implantable loop recorders (ILRs) from Medtronic (Reveal Linq) for use in trotter horses. They aim… Read More ›
Our colleagues Emelia Benjamin, Renate Schnabel and Isabelle C. Van Gelder has spearheaded this report from the U.S. National Heart, Lung, and Blood institute. It gives a nice overview of the current status of AF screening and highlights the knowledge… Read More ›
The strange year 2020 is coming to an end. It has been a challenging one for all of us. A year of digital meetings, a year without socializing at Lysebu or at workshops. Not the best conditions for networking. Nevertheless,… Read More ›
The Norwegian EXercise and Atrial Fibrillation Study (NEXAF) is a collaborative project within afib.no addressing research questions related to exercise and atrial fibrillation. The project includes three main work packages: Work package 1 is a randomized controlled trial of a… Read More ›
Several afib.no network members are involved in the OMega-3 fatty acids in Elderly with Myocardial Infarction (OMEMI) trial, investigating the effect of n-3 polyunsaturated fatty acids in patients aged 70-82 with recent myocardial infarction. The results were presented by Are… Read More ›
afib.no 